Records 1 - 4
| EDNRA variants associate with smooth muscle mRNA levels, cell proliferation rates, and cystic fibrosis pulmonary disease severity.
Physiological genomics 2010 Mar 41 (1): 71-7.
Darrah Rebecca, McKone Edward, O'Connor Clare, Rodgers Christine, Genatossio Alan, McNamara Sharon, Gibson Ronald, Stuart Elborn J, Ennis Madeleine, Gallagher Charles G, Kalsheker Noor, Aitken Moira, Wiese Dawn, Dunn John, Smith Paul, Pace Rhonda, Londono Douglas, Goddard Katrina A B, Knowles Michael R, Drumm Mitchell
| Nitric oxide synthase 1 as a potential modifier gene of decline in lung function in patients with cystic fibrosis.
Thorax 2004 Feb 59 (2): 156-8.
Texereau J, Marullo S, Hubert D, Coste J, Dusser D J, Dall'Ava-Santucci J, Dinh-Xuan A
| NOS1 polymorphism is associated with atopy but not exhaled nitric oxide levels in healthy children.
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2003 Aug 14 (4): 261-5.
Ali May, Khoo Siew-Kim, Turner Stephen, Stick Stephen, Le Souëf Peter, Franklin Pet
| Nasal nitric oxide levels in cystic fibrosis patients are associated with a neuronal NO synthase (NOS1) gene polymorphism.
Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society 2002 Mar 6 (2): 236-41.
Grasemann H, Storm van's Gravesande K, Gärtig S, Kirsch M, Büscher R, Drazen J M, Ratjen